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Streptavidin was crystallized on giant bilayer vesicles (20-60 ím) in sucrose solution at various pH
values. The streptavidin-coated vesicles exhibited unique roughened spherical and prolate ellipsoidal
shapes, illustrating resistance to curvature of the two-dimensional crystals. Studies indicated that the
spheroids and prolate ellipsoids correspond to different crystal morphologies. Through confocal microscopy,
the various crystal morphologies on vesicle surfaces were observed under different solution conditions.
Unlike two-dimensional (2D) streptavidin crystals grown in ionic buffer that assume the P1, P2, and C222
lattices at pH 4, 5.5, and 7, respectively (Wang et al. Langmuir 1999, 15, 1541), crystals grown in sucrose
with no added salt show only the lowest density C222 lattice due to strong electrostatic interactions.
Introduction
The delicate balance of forces governing ordering in
complex fluids produces many interesting and useful
phenomena.1 Ordering processes of particular interest are
those occurring in the two-dimensional assemblies of lipids
and proteins that create cell walls. These include inter-
estingstructural changesoccurring in the two-dimensional
protein coat on the tail sheath of the bacteriophage
injection apparatus during its penetration into a bacte-
rium2 and the S-layer proteins coating bacterial cell
surfaces.3 We believe that the complex phenomena oc-
curring in these biological systems can be traced to simple
intermolecular interactions triggered by changes in pH,
ionic strength, or polarity of the fluid environment. It is
our goal to unravel these biological mysteries through
systematic experiments on simple systems.
The protein streptavidin has been widely studied due
to its unique properties and potential uses.4-7 The ability
for streptavidin to crystallize into well-ordered arrays
creates potential for numerous applications in the field of
biosensors and biomaterials.8-10 The fact that streptavidin
molecules contain four biotin binding sites, two pairs on
opposite side of the molecules,6 makes them ideal as strong
cross-linkers. Due to the unusually high binding affinity
for biotin (10-15 M),5 the streptavidin-biotin system has
been widely exploited for various physical and biological
applications.4,11-14 Two-dimensional (2D) crystallization
of streptavidin has been studied on various surfaces such
as lipid monolayers at the air-water interface,15-19 lipid
bilayer membranes at solid-liquid interfaces,20 and lipid
nanotubes.21,22 Streptavidin had also been attached to
nanometer-size liposomes13,23 for linking to other biomol-
ecules, but to our knowledge, the study of streptavidin
crystallization on liposomes has not been reported.
In this work, we have crystallized streptavidin on the
surfaces of giant (>10 ím) lipid bilayer vesicles. Giant
unilamellar vesicles,24 typically ranging from 10 to 100
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ím in size, can be prepared through gentle hydration,25,26
rapid evaporation,27 or electroformation28-30 methods.
With a size comparable to biological cells, they can be
easily studied and manipulated and have led to significant
understanding of cell membrane properties such as
membrane adhesion,31,32 budding,33,34 and deformation.35
Our goal in this study is to understand the interplay
between protein layer crystallinity, vesicle morphology,
and the crystallization process. We have observed that
streptavidin crystals grown on lipid monolayers at the
air-water interface have pH-dependent morphologies.
Concurrent addition of the homologous protein avidin
allows the development of unique crystal shapes ranging
from needlelike to chiral inverse S-shaped and X-shaped
crystals, corresponding to different crystal structures.36
Avidin does not crystallize due to heterogeneous oligosac-
charide chains resulting from glycosylation and has been
added as a noncrystallizable impurity in 2D streptavidin
crystallization to dilute the streptavidin concentration at
the surface and to allow uninhibited growth of large crystal
domains.17,36-38 Whether thesestructureswillpersistwhen
grown on a vesicle surface in sucrose solutions of lower
ionic strength is the first question. Further investigating
the crystallization processes on vesicles allows us to deduce
the influence of a surface crystalline layer on vesicle shape.
Giant vesicles are ideal for this investigation due to their
large surface area, moderate curvature, and high flex-
ibility.
This study may also lead to applications in biotechnology
through the creation of well-ordered arrays of biological
linkers on a large spherical support, suitable for efficient
immobilization of various functionalized enzyme and
affinity ligands. Although similar concepts have been
reported with s-layer coated nanometer-sized liposomes,39
immobilization of other functionalized molecules onto
s-layers requires activation of the protein carboxylate
groups through the use of carbodiimide. Once activated,
the groups are subject to rapid hydrolysis, thus reducing
the coupling efficiency over time and frequently resulting
in significant number of defects and holes in the new
macromolecular layer. With the streptavidin-biotin sys-
tem, no such activation is necessary, and the coupling
affinity for biotinylated molecules remains high. In
conjunction with the fact that streptavidin is widely
commercially available and less expensive compared to
s-layers, crystalline streptavidin layers should provide
an effective template for immobilizing macromolecules
when a high degree of order and coupling efficiency is
desired.
Material and Methods
Vesicle Electroformation. Giant SOPC vesicles were made
via electroformation30 between two ITO (indium tin oxide) coated
glass (5 cm  4.5 cm  0.1 cm) electrodes in a Teflon chamber.
The chamber consists of a block of Teflon with a slot sufficiently
large to submerge the two electrodes in the formation medium
with a 0.5 mm gap in between. Before use, the Teflon chamber
and electrodes are thoroughly cleaned by repeated bath sonication
and rinsed with copious amounts of Milli-Q water (Millipore,
Bedford, MA). The lipid solution consisted of a 1 mg/mL mixture
of 10 wt % biotin-X-DHPE (N-[6-(biotinoylamino)hexanoyl]-1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylam-
monium salt) (Molecular Probes, Eugene, OR) and SOPC (1-
stearoyl-2-oleoyl-sn-glycero-3-phosphocholine) (Avanti, Alabaster,
AL) in pure chloroform. An aliquot of about 40 íL was spread
into a thin film on each ITO electrode and left to dry overnight
in a vacuum chamber. The two lipid-coated electrodes were then
put together in the Teflon chamber filled with 608 mOsm sucrose
solution. A Teflon spacer between the two glass surfaces prevents
contact. The vesicles were formed in an AC electric field (1 V, 10
Hz) for approximately 2 h at room temperature.
A small aliquot of the stock vesicle solution was injected into
a viewing cell filled with equal or slightly higher osmolality
glucose solution and 1 mg/mL bovine serum albumin (BSA)
(Sigma, St. Louis, MO) to prevent the vesicles from adhering to
the glass surface. The difference in solution density causes the
vesicles to sink to the bottom for easy observation, while the
index of refraction difference enhances contrast when viewed by
differential interference contrast (DIC). DIC microscopy was
performed with an inverse microscope (Axiovert 100S TV, Carl
Zeiss, Jena, Germany) equipped with an LD-Achroplan 40 
0.60 Korr lens (Carl Zeiss) and the recommended accessories for
DIC.
The vesicles were mostly between 20 and 60 micrometers in
diameter and remained stable in unbuffered sucrose solution for
at least 12 h. In these experiments, the vesicles were used within
5 h after electroformation.
Protein Labeling. Streptavidin and avidin were purchased
from Prozyme (San Leandro, CA). A portion of the two proteins
was labeled with Texas Red succinimidyl ester (single isomer)
(Molecular Probes, Eugene, OR) according to the supplied protocol
with minor modifications. Briefly, the proteins were dissolved in
100 mM sodium bicarbonate buffer, pH 8.3, to a concentration
of 2 mg/mL. The fluorescent dye was then dissolved in reagent-
grade dimethyl sulfoxide (DMSO; Sigma, St. Louis, MO) to a
concentration of 10 mg/mL and added to the protein solution at
a ratio of 1 dye/5 streptavidin molecules. The mixture was stirred
in the dark at room temperature for 2 h. The labeled protein was
separated from the unreacted dye by passage through a size-
exclusion column packed with Sephadex G25 (Sigma, St. Louis,
MO) and eluted with 50 mM sodium phosphate, pH 7.0. The
Texas Red dye was chosen because of its high resistance to
photobleaching. The final protein concentration and degree of
labeling were determined on a spectrophotometer by measuring
the absorbance at 280 and 595 nm, respectively. The final degree
of labeling was approximately 1 dye/10 streptavidin molecules.
Another portion of the remaining streptavidin and avidin was
labeled with FITC (fluorescein isothiocyanate) at a ratio of 2
dyes/protein molecule according to the method described by
Nargessi and Smith.40 The FITC-labeled proteins were used to
grow 2D streptavidin crystals on lipid monolayers.
We have observed that labeling streptavidin with fluorescent
dyes at these levels does not change the morphologies or
structures of crystals grown on lipid monolayers at the air-
water interface and that they were the same as those obtained
with unlabeled streptavidin.38
Crystal Formation on Vesicle Surfaces. To grow strepta-
vidin crystals on the surface of SOPC/biotin-X-DHPE vesicles,
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we added 80 íL of the newly electroformed vesicles to 420 íL of
the protein solution. The protein solution consists of either pure
streptavidin, streptavidin/TR avidin mixture, TR streptavidin/
avidin mixture, or pure TR streptavidin in 608 mOsm sucrose
at an overall concentration of 10-30 íg/mL. At 25 °C, the
saturation limit of sucrose in water is approximately 2160 mOsm
(1.97 M).41 Although not required for crystallization, high
concentrations of sucrose showed slight buffering capacity and
assisted in the precise control of the solution pH. Pure 608 mOsm
sucrose solution has a pH of approximately 5.0, and a pH range
from 4 to 7.5 of the protein solution was controlled by adding
0.1-2 íL of either 500 mM Tris, pH 10, or 500 mM MES, pH
3.15. MES and Tris were chosen since they provide greater
stability to the vesicles than other types of buffers tested. The
buffers were added mainly to adjust the pH of the solution, despite
the suboptimal buffering capacity under our particular experi-
mental pH conditions. Care was taken to keep the total buffer
concentration in the protein solution under 2 mM, as higher
buffer concentrations greatly reduce the stability of the vesicles.
The vesicles were incubated in the protein solution for at least
3 h at room temperature before observation.
Confocal Microscopy. We transferred the protein-coated
vesicles to a viewing cell filled with 618 mOsm glucose solution
containing 1 mg/mL BSA. The lower density of surrounding
glucose solution causes the sucrose-filled vesicles to sink to the
bottom of the cell and remain still during observation.
The confocal laser scanning microscope consists of a scanning
unit (Noran, Middleton, WI) attached to a Zeiss Axiovert 100 TV
(Zeiss, Germany). Texas Red molecules on the vesicles were
excited with a laser passing through a 568/590LP excitation/
emission filter set and viewed with an LD-Achroplan 40  0.60
Korr lens objective (Carl Zeiss). To prevent image superimposition
of crystals from opposite sides of the vesicle, we took image slices
of only the upper half of the vesicles at 0.5-1 ím intervals and
created a three-dimensional reconstruction with the Intervision
software package provided by Noran on a Silicon Graphics Indy
II computer (SGI Inc., Mountain View, CA).
Crystal Formation on Lipid Monolayer. We followed the
procedures for 2D crystallization of streptavidin at the air-water
interface described by Wang et al.38 with some modifications.
Briefly, eight circular wells (19 mm diameter, 3.5 mm deep) were
made on a 10 cm  8 cm  0.6 cm piece of black Delrin (Dupont,
Wilmington, DE). We drilled a small, needle-size injection port
into the side of each well so that material could be injected into
the solution without disrupting the surface. This design allowed
us to perform eight crystallization experiments simultaneously.
Before each use, the wells were soaked in chloroform for 1 h,
rinsed with chloroform, and rinsed with copious amount of filtered
Milli-Q water. The subphase consisted of either pH-adjusted 608
mOsm sucrose solution or a sodium phosphate buffer containing
50 mM NaH2PO4 and 500 mM NaCl, pH 4-7. We spread a
predetermined amount of 0.15 mg/mL 10:1 (wt %) mixture of
SOPC and biotin-X DHPE in 2:1 chloroform/methanol onto the
surface to achieve a surface pressure of 25-35 mN/m. The solvent
was allowed to evaporate for 15 min before a small aliquot of
either TR streptavidin or streptavidin/TR avidin mixture was
injected into the subphase through the injection port to a final
concentration of 20 íg/mL. The wells were left in the dark in a
covered, hydrated environment for at least 6 h before observation
in situ via fluorescence microscopy with the 20/0.50 NA Zeiss
Plan-Neofluar objective on a Zeiss Axioplan microscope (Zeiss,
Germany) equipped with a mercury arc lamp and 530-585/600/
615 nm excitation/dichroic beam splitter/emission filter set.
Images were taken with a Hamamatsu ORCA cooled CCD digital
camera (Hamamatsu, Japan) controlled by SimplePCI imaging
software (Compix, Inc., Cranberry Township, PA).
To prepare the samples for transmission electron microscopy
(TEM), the crystals were first stabilized by cross-linking with
50% glutaraldehyde for 4 h. This process does not alter the crystal
structure to within our resolution.38 The crystals were transferred
onto carbon-coated copper grids (Ted Pella Inc., Redding, CA),
washed, and stained with 1% uranyl acetate for 1 min. Details
of the transfer procedure can be found in Wang et al.36
The TEM images were taken on a Phillips CM20 electron
microscope at 42000-55000 and the negatives were digitized
by use of a Leaf45 scanner (Leaf Systems, Inc., Southborough,
MA), and processed by CRISP crystallographic image processing
software42 (Sollentuna, Sweden).
Results and Discussion
Figure 1 shows a differential interference contrast (DIC)
image of bare SOPC/biotin-X-DHPE vesicles. The vesicles
were perfectly spherical and elastic, similar to those made
of pure SOPC. When placed in a hypertonic glucose
solution, the vesicles shrink and thermal fluctuations are
clearly seen on the membrane.
When the bare vesicles were incubated in 100% avidin
solution, they became more rigid and membrane fluctua-
tions were no longer seen in hypertonic solution. The
vesicles remained smooth and spherical and showed an
elastic recovery after deformation similar to that of bare
vesicles.43
Confocal Study of Streptavidin Crystals on Vesicle
Surfaces. Vesicles incubated with a mixture of strepta-
vidin and TR avidin showed large streptavidin crystallites
when viewed under fluorescence. The number and size of
the crystallites increased with the streptavidin:TR avidin
ratio. Most vesicles coated with the streptavidin/avidin
mixture remained spherical, although at high streptavidin
ratios, some distortions were observed. In Figure 2 we
show three-dimensional (3D) reconstructed confocal mi-
croscopic images of the protein-coated vesicles grown in
sucrose at pH values ranging from 4.3 to 7. The crystals
of unlabeled streptavidin appear as black domains sur-
rounded by white regions of fluorescent avidin.
A number of observations can be made from Figure 2.
Crystals tend to form more readily in sucrose at pH 5.2
or below. At pH 6.3, only thin, elongated needles form,
while no macroscopic crystals were seen on the vesicles
at pH 7 or above. This transition from abundant to no
crystallization coincides well with the observed isoelectric
point (pI) of 5-6 for streptavidin.7 Unlike crystals grown
in ionic buffer solutions (50 mM NaH2PO4 and 500 mM
NaCl) at the air-water interface,36 the crystals in Figure
2 do not follow a definite morphological trend. Despite the
lack of a trend, the X-shaped and H-shaped crystallites
closely resemble those having C222 symmetry found on
monolayers. The crystallites also showed the preferential
growth direction characteristic of anisotropic conforma-
tional changes in the streptavidin molecules upon biotin
binding.6 We will later show that crystals grown on
monolayers over the same sucrose solution show the same
C222 symmetry, in agreement with the morphological
observations.
(41) Mathlouthi, M.; Reiser, P. Sucrose: Properties and applications;
Blackie Academic & Professional: London and New York, 1995.
(42) Hovmoller, S. Ultramicroscopy 1992, 41, 121-135.
(43) Ratanabanangkoon, P.; Gropper, M.; Merkel, R.; Sackmann, E.;
Gast, A. P. Manuscript in preparation.
Figure 1. DIC microscopic image of bare SOPC/biotin-X-DHPE
vesicles. Scale bar is 10 ím.
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VesicleShapeswithStreptavidinCrystals. Vesicles
coated with 100% streptavidin were very different from
the bare and avidin-coated vesicles. Instead of having
smooth spherical surfaces, the vesicles became rigid and
distorted with the presence of numerous creases and facets
indicative of a rigidification due to crystal formation. As
with vesicles coated with 100% avidin and streptavidin/
avidin mixtures, thermal undulations were not visible.
We observe two typical vesicle morphologies shown in
Figure 3. The first type (Figure 3A) is spherical vesicles
with rough surfaces, while Figure 3B shows a prolate
ellipsoidal vesicle with a relatively smoother surface.
According to micropipet studies, both types of vesicles are
very rigid and exhibit plastic behavior, as indicated by
permanent deformations when they are stressed beyond
their yield point.43
The ellipsoidal vesicles also contained unique ridges on
the surface running along the major axis. These two
morphologies were typically seen coexisting within the
same sample with an increasing number of ellipsoids at
higher pH.
Table 1 summarizes the effect of incubation time and
incubation solution pH on the relative number of the two
different vesicle morphologies. The bare vesicles were
incubated in 608 mOsm sucrose solution containing 20
íg/mL streptavidin at either pH 5 or pH 6. After the
specified incubation times, a small aliquot was taken and
inspected in 660 mOsm glucose solution. Fewer than half
Figure 2. Three-dimensional reconstructed confocal microscopic images of various streptavidin crystal morphologies on giant
bilayer vesicles at the indicated pH. The vesicles were coated with a 1:1 mixture of streptavidin and Texas Red avidin. To prevent
crystal domains from opposite sides of the vesicles from superimposing, image slices (1 ím thickness) of only the upper half of each
vesicle were taken and digitally reconstructed. Streptavidin crystals appear black surrounded by noncrystallizable Texas Red
avidin (white). Note that at pH 7 no streptavidin crystals can be seen. Scale bar under each vesicle represents 10 ím.
Figure 3. DIC microscopic images show two shapes observed
among streptavidin-coated vesicles. (A) Rough surfaces have
many ridges and edges. (B) Ellipsoids are smoother with
characteristic ridges running parallel to the major axis. Scale
bar is 20 ím.
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of the vesicles incubated in pH 5 sucrose solution
transformed into prolate ellipsoids, while the majority of
vesicles incubated at pH 6 made such a transformation.
It is also noticed that most of the morphological changes
occurred within 1 h when vesicles were incubated in the
pH 5 sucrose solution. On the other hand, vesicles
incubated at pH 6 showed a much slower transition over
a period of at least 3 h.
The presence of prolate ellipsoidal vesicles was almost
exclusively seen in vesicles coated with 100% streptavidin.
Vesicles usually remain spherical in the presence of
noncrystallizable avidin. One of the exceptions, an el-
lipsoidal vesicle coated with a streptavidin/avidin mixture,
is shown in Figure 4. Unlike most streptavidin/avidin-
coated vesicles, where the streptavidin crystallites form
isolated and randomly oriented domains, the vesicle in
Figure 4 shows long, continuous crystals across the entire
vesicle. The formation of a thin, elongated shape of the
streptavidin crystals on the vesicle suggests a strong
preferred growth direction, as seen with streptavidin
crystals grown on lipid monolayers.36
The confocal microscopy suggested that the ellipsoids
were composed of thin, continuous, needle-shaped crystals
with parallel growth directions. The strong crystal shape
anisotropy along with the parallel growth pattern resulted
in the elongation of the vesicle along one direction, as the
bending rigidity of the crystallites is higher than that of
the surrounding matrix. At high pH, fewer nucleation
sites were present due to retardation factors such as
electrostatic repulsion, and crystal growth was relatively
slower than that at lower pH. The slow crystal growth
and fewer nucleation sites allowed the formation of large
crystallites with fewer defects, hence the smoother surface
compared to the roughened spherical vesicles.
The distortion of vesicles due to crystallized protein
molecules at the surface has been observed with bacterium
Comamonas acidovorans surface layer proteins when
reconstituted on lipid vesicles.44 Micrometer-size vesicles
covered with protein crystals were distorted into various
shapes such as spheres, cylinders, and cones. The protein
is thought to anchor into the membrane via a small
hydrophobic domain. Through electron microscopy, Paul
and co-workers44 have shown that distortion of the vesicle
surface requires the proteins to form 2D self-contained
and continuous crystalline envelopes around parts of the
surface. This is analogous to our system. The strong
coupling between streptavidin and the lipid membrane
was provided via the streptavidin-biotin interaction with
the biotinylated lipid acted as hydrophobic anchors
securing the proteins to the vesicle surface. Although the
interaction between streptavidin and biotin is very strong,
the system can relax due to reorientation and relocation
of the streptavidin-biotinylated lipid complex within the
fluid matrix. The 2D crystals observed here (space group
C222) have been shown to be sufficiently flat to template
the growth of 3D (space group I122) streptavidin crystals,
which consist of a stack of the 2D array.18 This shows that
the C222 form of 2D streptavidin crystal is capable of
forming flat crystal domains and should not impose any
significant bending on the vesicle membrane. The presence
of multiple flat crystalline domains separated by defects
and grain boundaries results in the rough vesicle surface
observed. Both effects, relaxation within the fluid matrix
and flatness of the crystals, are important for the integrity
of the giant unilamellar vesicles during crystal growth.
The observed continuous, self-contained crystal envelope
also agrees with our observation that ellipsoidal vesicles
have smoother surfaces, indicating the presence of larger
crystals with fewer defects.
Crystals on the roughened spheres grew differently from
those of ellipsoids. The roughened spheres tend to be found
more often below pH  5.5. We observed from monolayer
experiments that nucleation occurs much faster at lower
pH; the same trend was observed on bilayer vesicles
yielding more but smaller crystallites on the surface. [This
applies to vesicles coated with 100% streptavidin. In
vesicles that are coated with streptavidin/avidin mixtures
such as those shown in Figure 2, the presence of non-
crystallizable avidin dilutes the streptavidin concentration
at the vesicle surface. This results in slower crystal growth
and larger domains as seen on some of the vesicles.] Due
to the rapid nucleation and growth of the crystallites, they
tend to be randomly oriented, creating many defects and
grain boundaries. As a result, the crystallites are not
sufficiently aligned to impose a uniform curvature on the
entire vesicle. Thus, these vesicles remain relatively round
with patches of small rigid crystallites on the surface.
As mentioned previously, the crystals observed on
bilayer vesicles lack a clear morphological trend at
different pH values unlike those grown in ionic buffer
solutions. Thus, the crystal structure could not be readily
deduced from morphology and previous experiences with
monolayer systems.
Monolayer Experiments. The obvious question re-
mains: do streptavidin crystals grown on bilayer vesicles
in sucrose exhibit the same diverse crystal structures at
various pH values as those grown in buffer systems on
lipid monolayers? Because the SOPC/biotin-X-DHPE
vesicles were not stable in high ionic strength solutions,
we could not grow streptavidin crystals on vesicles in the
buffer normally used in monolayer experiments. It is thus
not possible to compare crystal morphologies from the
two systems in buffer.
Instead, we address this question through a series of
monolayer experiments. We grew streptavidin crystals
on a lipid monolayer with sucrose solution as a subphase
at various pH values. Figure 5 shows a comparison of
crystal morphologies at different pH values.
In sucrose, streptavidin crystals were denser and more
abundant when grown with 100% streptavidin. The
(44) Paul, A.; Engelhardt, H.; Jakubowski, U.; Baumeister, W.
Biophys. J. 1992, 61, 172-188.
Table 1. Effect of Incubation Time and Incubation
Solution pH on Vesicle Morphologies











1 36 64 134 43 57 112
3 34 66 126 60 40 132
5 36 64 131 65 35 133
Figure 4. Three-dimensional reconstructed confocal micro-
scopic image of a prolate ellipsoid vesicle coated with a mixture
of Texas Red avidin and streptavidin. The streptavidin crystals
can be seen as thin, dark longitudinal lines. Scale bar is 20 ím.
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presence of avidin diluted the streptavidin concentration
at the surface and acted to retard nucleation and slow
growth, as seen on the bilayer vesicles. Another similar
trend observed among monolayer and bilayer vesicles is
that fewer streptavidin crystals formed at higher pH,
presumably due to the influence of the electrostatic
repulsions at low ionic strengths. By adding sodium
chloride to the sucrose solution at pH 7 to screen the
electrostatic interactions, we were able to retrieve abun-
dantcrystals showingasquare latticewith C222symmetry
when the streptavidin/TR avidin mixture was used. Along
with the observation that fewer crystals were obtained at
pH 7 with the addition of avidin, we conclude that both
electrostatic interactions at high pH and the dilution of
noncrystallizable avidin were responsible for impeding
streptavidin crystallization.
One effect of electrostatic interactions on avidin systems
has been illustrated by Velev23 with nanometer-size
biotinylated liposomes and avidin-ferritin conjugates.
There they observed that, at pH 4, the avidin-ferritin
molecules bound to the liposomes, but at pH 7, binding
did not occur since both moieties were negatively charged.
Only when positive cationic surfactant hexadecyltri-
methylammonium bromide (HTAB) was mixed into the
liposome to generate a more electrostatically favorable
condition did avidin-ferritin conjugates begin to coat the
liposomes. In our case, however, the electrostatic inter-
actions were not strong enough to completely inhibit
protein binding on the vesicles but were sufficient to
obstruct crystallization.
Unlike thecrystalsgrowninhigher ionic strengthbuffer,
analysis of lipid monolayer crystals grown in sucrose show
the C222 space group at pH 4, 5.5, and 7. The electrostatic
repulsions apparently prevent the higher density P1 and
P2 crystal forms from occurring. We expect the monolayer
crystals to closely resemble those on vesicle surfaces. Since
the curvature of giant vesicles is negligible relative to
individual streptavidin molecules, the vesicle surface is
indistinguishable from that of lipid monolayers. In ad-
dition, the use of the same lipid mixtures and solution
conditions produces comparable molecular interactions,
and the same crystal structures, as previously confirmed
with s-layer proteins.39,45-47 The existence of one crystal
structure in sucrose was consistent with the X-shaped
and H-shaped morphologies seen on the surface of giant
vesicles at low pH.
Conclusions
We have shown that streptavidin can be successfully
crystallized on surfaces of giant biotinylated phospholipid
(45) Pum, D.; Weinhandl, M.; Ho¨dl, C.; Sleytr, U. B. J. Bacteriol.
1993, 175, 2762-2766.
(46) Wetzer, B.; Pfandler, A.; Gyo¨rvary, E.; Pum, D.; Lo¨sche, M.;
Sleytr, U. B. Langmuir 1998, 14, 6899-6906.
(47) Pum, D.; Sa´ra, M.; Sleytr, U. B. J. Bacteriol. 1989, 171, 2596-
5303.
Figure 5. Fluorescence microscopic images comparing streptavidin crystal morphologies grown on lipid monolayers in either
sucrose or phosphate buffer at various pH. The molecular arrangement is summarized along with the corresponding space group
from Wang et al.36 for comparison. Scale bar at bottom left is 100 ím.
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vesicles in sucrose solution. The crystal-coated vesicles
took on either a spherical or prolate ellipsoidal appearance
with a narrow aspect ratio distribution. By performing
laser scanning confocal microscopy on the crystal-coated
vesicles, we found that roughened spheres and ellipsoids
formed via different mechanisms. Roughened spheres
carry smaller, randomly oriented crystalline patches on
the vesicle surface, whereas ellipsoids tend to have larger,
continuous crystallites with fewer grain boundaries and
defects. Confocal microscopy also allowed us to observe
various crystal morphologies on vesicle surfaces under
different solution conditions. The number and size of
crystal domains can be roughly controlled by the addition
of noncrystallizable avidin and by controlling the solution
pH. The crystal morphologies do not follow the trend
normally seen with those grown on lipid monolayers in
ionic buffer solutions at various pH values. Due to the
lack of ionic species in sucrose solution, the electrostatic
repulsion prevented other higher density crystal struc-
tures from forming, and only the lowest density C222
symmetry was observed.
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